+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neovii Pharmaceuticals AG - logo

Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. It focuses on solid organ transplantation, stem cell transplantation and immune and hemato-oncological disorders. Founded in 2003, Neovii's global headquarters are located in Rapperswil, Switzerland. Its headquarters in the United States are in Waltham, MA. It employs approximately 150 people and has presence in nearly 60 countries worldwide.

From
From
Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

  • Report
  • January 2020
  • 410 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
From
From
From
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
From
Cancer Immunotherapy Global Market Report 2024 - Product Thumbnail Image

Cancer Immunotherapy Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
  • 17 Results (Page 1 of 1)
Loading Indicator